Genetic factors identified in female sexual dysfunction

Genetic factors identified in female sexual dysfunction
At least two genetic factors are involved in female sexual disorder symptomatology in addition to non-shared environmental effects, according to the results of a twin study published online Aug. 2 in The Journal of Sexual Medicine.

(HealthDay) -- At least two genetic factors are involved in female sexual disorder (FSD) symptomatology in addition to non-shared environmental effects, according to the results of a twin study published online Aug. 2 in The Journal of Sexual Medicine.

Andrea Burri, Ph.D., of King's College London, and colleagues conducted a study involving 1,489 female twins aged 18 to 85 years to determine the genetic and associated with the major subtypes of FSD. The participants included 244 monozygotic twin pairs, 189 dizygotic ; and 623 women who participated without their co-twin.

The researchers found that the model which best fit FSD was an ACE Cholesky model, which included additive genetic effects and non-shared environmental effects. Significant genetic sharing was seen between desire, arousal, lubrication, and orgasm, in addition to genetic sharing between arousal, lubrication, and orgasm, which was independent of desire. These effects were small to modest (7 to 33 percent). A third of the covariance between these dimensions was suggested to be genetic, based on bivariate heritabilities. Lubrication and orgasm shared the least amount of genetic correlation with desire. Non-shared environmental effects were stronger than genetic effects and more dimension-specific.

"In conclusion, our results show FSD to be etiologically heterogeneous in terms of its underlying genetic and environmental factor structure," the authors write. "Specific sexual dimensions were found to be influenced by two common as well as relatively dimension-specific non-shared environmental factors."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Sexual satisfaction in women increases with age

Jan 03, 2012

A new study of sexually active older women has found that sexual satisfaction in women increases with age and those not engaging in sex are satisfied with their sex lives. A majority of study participants report frequent ...

Genetic link found between anxiety, depression and insomnia

Jun 08, 2009

The genes that play a role in adolescent insomnia are the same as those involved in depression and anxiety, according to a research abstract that will be presented at SLEEP 2009, the 23rd Annual Meeting of the Associated ...

Recommended for you

No danger of cancer through gene therapy virus

2 hours ago

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

The secret of DNA methylation

Jun 18, 2013

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression ...

Aspirin may fight cancer by slowing DNA damage

Jun 18, 2013

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

Study identifies protein essential for normal heart function

Jun 17, 2013

A study by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology at the University of California, San Diego, shows that a protein called MCL-1, which promotes cell survival, ...

Scouring the genome of adenoid cystic carcinoma

Jun 17, 2013

Adenoid cystic carcinoma (ACC) is a slow-growing and often fatal malignancy that can occur at multiple organ site, but is most frequently found in the salivary glands. The primary treatment is surgical removal; however, the ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.